Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin in Major Liver Resection
NCT01921985Phase 2Terminated
- Sponsor
- Insel Gruppe
- Start
- Nov 2013
- Primary completion
- Mar 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terlipressin in liver failure, sponsored by Insel Gruppe. Started Nov 2013; status: terminated.
02
Drugs
terlipressin
03
Conditions
liver failure
Beyond the preview
Go deeper on NCT01921985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921985.